Fred E. Cohen

Fred E. Cohen is recorded as Board Member at Kyverna Therapeutics, Inc. (KYTX) since January 1, 2018 and Board Member at CareDx, Inc. (CDNA) since January 1, 2003. The newest filing on record that lists Fred E. Cohen as Board Member at Kyverna Therapeutics, Inc. (KYTX) is dated April 13, 2026. The newest filing on record that lists Fred E. Cohen as Board Member at CareDx, Inc. (CDNA) is dated April 28, 2025. Fred E. Cohen was last confirmed as Board Member at Progyny, Inc. (PGNY) in a filing dated April 12, 2024. Fred E. Cohen was last confirmed as Board Member at Veracyte, Inc. (VCYT) in a filing dated April 23, 2021. Earlier roles on record: Board Member at UroGen Pharma Ltd. (URGN) until September 12, 2024. UroGen Pharma Ltd. reported in an 8-K filed September 13, 2024 that Fred E. Cohen resigned as director, effective September 12, 2024. CareDx, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CareDx, Inc. includes Alexander L. Johnson (CEO), John W. Hanna (CEO and Board Member), Michael D. Goldberg (Chairman and Board Member) and 7 others.